Cover Image
市場調查報告書

生長激素分泌不全症:全球臨床實驗趨勢

Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 240570
出版日期 內容資訊 英文 93 Pages
訂單完成後即時交付
價格
Back to Top
生長激素分泌不全症:全球臨床實驗趨勢 Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月30日 內容資訊: 英文 93 Pages
簡介

本報告提供生長激素分泌不全症臨床實驗相關之最新趨勢分析,提供您各地區臨床實驗數量,臨床實驗各階段進展,實驗對象採用狀況,並彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 生長激素分泌不全症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:代謝性疾病治療藥臨床實驗上生長激素分泌不全症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:代謝性疾病治療藥臨床實驗上生長激素分泌不全症所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

生長激素分泌不全症臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novo A/S
    • Pfizer Inc.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • Canbex Therapeutics Ltd.
    • E. Merck KG
    • LG Life Sciences, Ltd.
    • Ferring International Center S.A.
    • Teva Pharmaceutical Industries Limited
    • OPKO Health, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Aarhus University
    • Federico II University
    • Massachusetts General Hospital
    • Oregon Health & Science University
    • Columbia University
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Sahlgrenska University Hospital
    • University of Pennsylvania
    • Aarhus University Hospital
    • Assaf-Harofeh Medical Center

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2758CTIDB

GlobalData's clinical trial report, "Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015" provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Growth Hormone Deficiency
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Growth Hormone Deficiency
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Growth Hormone Deficiency Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Growth Hormone Deficiency
      • Jun 25, 2015: Aeterna Zentaris Announces Selection of Ergomed to Conduct Confirmatory Phase 3 Clinical Trial of Macrilen in AGHD
      • May 26, 2015: Aeterna Zentaris' Confirmatory Phase 3 Study for Macrilen in AGHD Meets EMA's Study-Design Expectations
      • Apr 13, 2015: Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen in AGHD Following Successful Meeting with FDA
      • Apr 13, 2015: Versartis Initiates Phase 2/3 Trial of VRS-317 in Japan for Children With Growth Hormone Deficiency
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novo A/S
      • Clinical Trial Overview of Novo A/S
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Canbex Therapeutics Ltd.
      • Clinical Trial Overview of Canbex Therapeutics Ltd.
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • LG Life Sciences, Ltd.
      • Clinical Trial Overview of LG Life Sciences, Ltd.
      • Ferring International Center S.A.
      • Clinical Trial Overview of Ferring International Center S.A.
      • Teva Pharmaceutical Industries Limited
      • Clinical Trial Overview of Teva Pharmaceutical Industries Limited
      • OPKO Health, Inc.
      • Clinical Trial Overview of OPKO Health, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Aarhus University
      • Clinical Trial Overview of Aarhus University
      • Federico II University
      • Clinical Trial Overview of Federico II University
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Oregon Health & Science University
      • Clinical Trial Overview of Oregon Health & Science University
      • Columbia University
      • Clinical Trial Overview of Columbia University
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Sahlgrenska University Hospital
      • Clinical Trial Overview of Sahlgrenska University Hospital
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • Aarhus University Hospital
      • Clinical Trial Overview of Aarhus University Hospital
      • Assaf-Harofeh Medical Center
      • Clinical Trial Overview of Assaf-Harofeh Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Region, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Canbex Therapeutics Ltd., 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by OPKO Health, Inc., 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Federico II University, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2015*

List of Figures

  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015*
  • Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top